Author

O. Croci

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1 Immunology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Organism:human· 2 Assay:bulk RNA-seq· 1 Research Focus:cancer & tumor microenvironment· 1 Research Focus:cell signaling & trafficking· 1 Research Focus:cell type annotation· 1 Research Focus:differential expression· 1 Research Focus:drug response / drug discovery· 1

Frequent Co-Authors

A. Boletta· 1 shared A. D. Macandog· 1 shared A. Ghsein· 1 shared A. Verrecchia· 1 shared B. Amati· 1 shared C. B. Nava Lauson· 1 shared C. Catozzi· 1 shared C. Scirgolea· 1 shared

Activity by Year

2021-2022 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 21 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

A. Boletta

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Oxidative stress potentiates the therapeutic action of a mitochondrial complex I inhibitor in MYC-driven B-cell lymphoma

G. Donati, P. Nicoli, A. Verrecchia, V. Vallelonga, O. Croci, S. Rodighiero, M. Audano, L. Cassina, A. Ghsein, G. Binelli, A. Boletta, N. Mitro, B. Amati

This study shows that combining a mitochondrial complex I inhibitor with oxidative stress inducers enhances the killing of MYC-driven lymphoma cells.

bioRxiv · Jun 21, 2022 · PreprintCancer Biology

GZMKhigh CD8+ T effector memory cells are associated with CD15high neutrophil abundance in early-stage colorectal tumors and predict poor clinical outcome.

S. Tiberti, C. Catozzi, C. Scirgolea, O. Croci, M. Ballerini, D. Cagnina, C. Soriani, A. D. Macandog, C. B. Nava Lauson, G. Bertalot, W. L. Petz, S. P. Ravenda, V. Licursi, P. Paci, M. Rasponi, , T. o. MANZO

The paper identifies GZMKhigh CD8+ T effector memory cells in early-stage CRC tumors, which correlate with neutrophil abundance and predict poor clinical outcomes.

bioRxiv · Dec 14, 2021Immunology